<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Maria Jerónimo - Portfólio</title>
    <link rel="icon" type="image/png" href="assets/star2.png">
  <link href="https://fonts.googleapis.com/css2?family=Roboto+Slab:wght@400;700&display=swap" rel="stylesheet">

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Cedarville+Cursive&family=Roboto+Slab:wght@100..900&display=swap" rel="stylesheet">

  <link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Cedarville+Cursive&family=Nunito:ital,wght@0,200..1000;1,200..1000&family=Oswald:wght@200..700&family=Roboto+Slab:wght@100..900&display=swap" rel="stylesheet">

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Cedarville+Cursive&family=Nunito:ital,wght@0,200..1000;1,200..1000&family=Oswald:wght@200..700&family=Roboto+Slab:wght@100..900&family=Zalando+Sans+SemiExpanded:ital,wght@0,200..900;1,200..900&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="style.css">
  <!-- <link rel="stylesheet" href="style-projects.css"> -->
<link
  rel="stylesheet"
  href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.1/css/all.min.css"
/>

</head>
<body>
<header>

    <nav>
      <a href="index.html" class="logo cedarville-cursive-regular">Maria Jerónimo</a>
    </nav>
  </header>
  <main>
    <h1 class="oswald, purple">Understanding Self-Tracking Practices in Enigmatic Disease Management </h1>
<p class="oswald">A research project exploring how to design tools that better support people living with enigmatic diseases as they manage their condition over time.</p>

<section class="hero-image">
  <img 
    src="assets/selftracking1.jpg" 
    alt="Understanding Self-Tracking Practices in Enigmatic Disease Management" 
  />
</section>
<br>
<br>

    <h2> The Problem <i class="fa-solid fa-question"></i></h2>
    <hr class="linha">
    <p>Self-tracking tools are often built around the assumption that tracking  the “right” health variables will lead to actionable insights and greater control over one’s health. Yet, it remains unclear how these  assumptions hold up in contexts marked by uncertainty, unpredictability, and frequent fluctuations in health needs, such as those experienced in enigmatic conditions. </p>
<br>
<p>For context, <b>Enigmatic Diseases</b> are defined as:</p>

<section class="diseases">
  <div class="characteristic">
    <i class="fa-regular fa-clock" style="color: #3d2645;"></i>
    <h3>Chronic</h3>
  </div>

  <div class="characteristic">
    <i class="fa-solid fa-magnifying-glass" style="color: #3d2645;"></i>
    <h3>Multifactorial nature</h3>
  </div>

  <div class="characteristic">
    <i class="fa-solid fa-book" style="color: #3d2645;"></i>
    <h3>Poorly understood</h3>
  </div>

  <div class="characteristic">
    <i class="fa-regular fa-comments" style="color: #3d2645;"></i>
    <h3>Individual experiences</h3>
  </div>

  <div class="characteristic">
    <i class="fa-solid fa-chart-line" style="color: #3d2645;"></i>
    <h3>Fluctuations</h3>
  </div>

  <div class="characteristic">
    <i class="fa-regular fa-face-frown" style="color: #3d2645;"></i>
    <h3>Emotional burden</h3>
  </div>
</section>
<br>
<p> Some examples include: <b>Crohn’s disease, Ulcerative Colitis, Endometriosis, Rheumatoid Arthritis,</b> ...</p>
<br>

<br>
 <h2> The Ideia </i></h2>
<hr class="linha">
<section class="comparison">
  <div class="column">
    <h2>Previous Work</h2>
    <ul>
      <li><strong>Most studies focused on a single diagnosis</strong>, tailoring tools for specific conditions.</li>
      <li>These efforts emphasize what to track and how such data might inform a broader understanding of a particular enigmatic disease.</li>
      <li>While effective, this approach may overlook broader, shared experiences across diseases.</li>
    </ul>
  </div>

  <div class="column">
    <h2>Our Approach</h2>
    <ul>
      <li>Focus on <strong>when</strong> and <strong>why</strong> people track.</li>
      <li><strong>Include multiple enigmatic diseases</strong> to identify commonalities and contrasts in tracking needs.</li>
      <li>Explore how these needs evolve over time as individuals manage their conditions.</li>
    </ul>
  </div>
</section>
<br>

 <h2> Methodology</i></h2>
<hr class="linha">
<br>
    <h3>Recruitment</h3>
    
    <p>Recruitment was carried out through multiple complementary channels. We posted targeted study invitations in disease
focused Facebook groups and Reddit communities, and worked with local patient associations, who disseminated our
 call through mailing lists, WhatsApp groups, and online networks.</p>
  
<div class="img_center">
    <img 
    src="assets/Flyer.jpg" 
    alt="Flyer" 
  />
</div>
 <h3>Participants</h3>

    <p class="purple"><strong>Eligibility criteria:</strong></p>
    <ol>
      <li>Individuals formally diagnosed with at least one enigmatic condition and,</li>
      <li>who had engaged in any form of self-tracking at least once in relation to their condition.</li>
    </ol>

    <!-- <ul class="stats">
      <li><strong>Total:</strong> 23 participants</li>
      <li><strong>Age range:</strong> 24–49 years old</li>
      <li><strong>Gender:</strong> 20 Female and 3 Male</li>
    </ul> -->
  </div>




<div class="table-card">
<table class="participants-table">
  <thead>
    <tr>
      <th>Id</th>
      <th>Age</th>
      <th>Gender</th>
      <th>Occupation</th>
      <th >Country of Origin</th>
      <th>Enigmatic Diseases and Age of Diagnosis</th>
    </tr>
  </thead>

  <tbody>
    <tr><td>P1</td><td>30</td><td>F</td><td>Student</td><td >Portugal</td><td>ulcerative colitis (28); axial spondyloarthritis (axSpA) (28), migraine (Childhood)</td></tr>
    <tr><td>P2</td><td>31</td><td>F</td><td>Unemployed</td><td >Portugal</td><td>Crohn's disease (18); endometriosis (under investigation)</td></tr>
    <tr><td>P3</td><td>40</td><td>F</td><td>Freelancer</td><td >Portugal</td><td>endometriosis (39)</td></tr>
    <tr><td>P4</td><td>24</td><td>F</td><td>Receptionist</td><td >Canada</td><td>fibromyalgia (16)</td></tr>
    <tr><td>P5</td><td>35</td><td>F</td><td>Unemployed</td><td >Portugal</td><td>ulcerative colitis (23); Hashimoto's thyroiditis (23)</td></tr>
    <tr><td>P6</td><td>48</td><td>F</td><td>Unemployed</td><td >Portugal</td><td>ulcerative colitis (19); lupus (21)</td></tr>
    <tr><td>P7</td><td>27</td><td>F</td><td>Student</td><td >Portugal</td><td>Crohn's disease (22)</td></tr>
    <tr><td>P8</td><td>40</td><td>F</td><td>Association President</td><td >Portugal</td><td>endometriosis / adenomyosis (23)</td></tr>
    <tr><td>P9</td><td>30</td><td>F</td><td>Company Employee</td><td >Portugal</td><td>endometriosis (27), Behçet’s disease (27), autoimmune neurological disease (under investigation)</td></tr>
    <tr><td>P10</td><td>30</td><td>F</td><td>Real Estate Manager</td><td>Portugal</td><td>ulcerative colitis (15)</td></tr>
    <tr><td>P11</td><td>44</td><td>F</td><td>Administrator</td><td >USA</td><td>fibromyalgia (35); rheumatoid arthritis (under investigation)</td></tr>
    <tr><td>P12</td><td>48</td><td>F</td><td>Professor</td><td >USA</td><td>fibromyalgia (14)</td></tr>
    <tr><td>P13</td><td>29</td><td>F</td><td>Research Coordinator</td><td >Canada</td><td>fibromyalgia (20)</td></tr>
    <tr><td>P14</td><td>38</td><td>M</td><td>Senior Manager</td><td >Canada</td><td>fibromyalgia (38)</td></tr>
    <tr><td>P15</td><td>33</td><td>F</td><td>Cloud Security Engineer</td><td >USA</td><td>fibromyalgia (32); endometriosis</td></tr>
    <tr><td>P16</td><td>49</td><td>F</td><td>Writer</td><td >USA</td><td>Hashimoto's thyroiditis (47), fibromyalgia (47)</td></tr>
    <tr><td>P17</td><td>39</td><td>M</td><td>Marketing</td><td >USA</td><td>fibromyalgia (15), vestibular migraine (37)</td></tr>
    <tr><td>P18</td><td>29</td><td>F</td><td>Unemployed</td><td >UK</td><td>fibromyalgia (22); functional neurological disorder (FND) (26)</td></tr>
    <tr><td>P19</td><td>24</td><td>M</td><td>Software Engineer</td><td >UK</td><td>psoriasis (12)</td></tr>
    <tr><td>P20</td><td>31</td><td>F</td><td>Preschool Teacher</td><td >Brazil</td><td>rheumatoid arthritis (30)</td></tr>
    <tr><td>P21</td><td>45</td><td>F</td><td>Civil Rights Coordinator</td><td >USA</td><td>rheumatoid arthritis (39)</td></tr>
    <tr><td>P22</td><td>36</td><td>F</td><td>Unemployed</td><td >USA</td><td>rheumatoid arthritis (8)</td></tr>
    <tr><td>P23</td><td>30</td><td>F</td><td>Dental Implant Liaison</td><td >USA</td><td>rheumatoid arthritis (27), axial spondyloarthritis (axSpA) (under investigation)</td></tr>
  </tbody>
</table>
</div>

  </main>
    <footer>
  <div class="grid_footer">

    <div class="footer_title">
      <h3>Let’s Keep In Touch <i class="fa-solid fa-arrow-pointer"></i></h3>
    </div>

    <div class="footer_contact">
      <p>Lisbon, Portugal</p>
      <p><span style="color: gray;">Email:</span> mariacjeronimo02@gmail.com</p>

    </div>

    <div class="footer_meta">
      <p>© Maria Jerónimo 2025</p>
      
    </div>

    <div class="footer_socials">
  <a href="https://www.linkedin.com/in/maria-jer%C3%B3nimo/" target="_blank" aria-label="LinkedIn">
    <i class="fa-brands fa-linkedin-in"></i>
  </a>

  <a href="mailto:mariacjeronimo02@gmail.com" aria-label="Email">
    <i class="fa-solid fa-envelope"></i>
  </a>

  <a href="https://github.com/mariacjeronimo" target="_blank" aria-label="GitHub">
    <i class="fa-brands fa-github"></i>
  </a>
</div>

  </div>
</footer>
</body>

</html>